Hikma is an England-based multinational pharmaceutical firm that manufactures and distributes generic and in-licensed pharmaceutical products for healthcare organizations.
Business Model:
Revenue: $2.6B
Employees: 5,001-10,000
Address: 1 New Burlington Place
City: London
State: england
Zip: W1S 2HR
Country: GB
Hikma is an England-based multinational pharmaceutical firm that manufactures and distributes generic and in-licensed pharmaceutical products for healthcare organizations.
Contact Phone:
Contact Email:
Listed Exchange:
London Stock Exchange
IPO Date:
11/11/2005
Ticker Symbol:
HIK
Opened: -/share
EBITDA | - |
Total Cash | - |
Total Debt | - |
Total Revenue | - |
Total Profit (Gross) | - |
PE Ratio | - |
Announced Date | Company | Transaction | Money Raised |
---|---|---|---|
4/2011 | Unimark Remedies | Funding Round | 33.3M |
4/2011 | Unimark Remedies | Funding Round | 0 |
Announced Date | Transaction | Number of Investors | Money Raised | Lead Investors |
---|
Announced Date | Name | Price |
---|---|---|
9/2021 | Custopharm | |
9/2015 | EIMC United Pharmaceuticals | |
7/2015 | Roxane Laboratories | |
5/2014 | Bedford Laboratories | |
1/2013 | Egyptian Company for Pharmaceuticals &a; Chemical Industries | |
10/2011 | Promopharm | |
12/2007 | The Arab Pharmaceutical Manufacturing Co. Ltd. | |
8/2007 | Alkan Pharma | |
5/2007 | Thymoorgan Pharmazie GmbH | |
4/2006 | Jazeera Pharmaceuticals Industries |
|
Revenue: 0 - 100000 Employees: Industry: Software |
Details
|
|
Revenue: 0 - 100000 Employees: 51 - 500 Industry: Education |
Details
|
|
Revenue: 0 - 100000 Employees: 1 - 10 Industry: Blockchain |
Details
|
|
Revenue: 0 - 100000 Employees: 11 - 50 Industry: Industrial |
Details
|
|
Revenue: 0 - 100000 Employees: 1 - 10 Industry: Advertising |
Details
|